CS logo
small CS logo
Hospital Xeral

Lugo, Spain

About Hospital Xeral


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Hospital Xeral


During the past decade, Hospital Xeral conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Hospital Xeral


According to Clinical.Site data, the most researched conditions in "Hospital Xeral" are "Acute Lymphoblastic Leukemia" (1 trials), "Acute Myeloblastic Leukaemia" (1 trials) and "Diffuse Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Hospital Xeral" in a lesser frequency.

Clinical Trials Intervention Types at Hospital Xeral


Most popular intervention types in "Hospital Xeral" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "ARA-C" (1 trials), "ASP" (1 trials), "Cytarabine" (1 trials), "Cytosine Arabinoside" (1 trials) and "Daunorubicin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital Xeral


The vast majority of trials in "Hospital Xeral" are 3 trials for "All" genders.

Clinical Trials Status at Hospital Xeral


Currently, there are NaN active trials in "Hospital Xeral". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Xeral, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Xeral, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".